Byrne Asset Management’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-6,600
Closed -$14.5K 572
2024
Q4
$14.5K Buy
+6,600
New +$14.5K 0.01% 342